SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000902664-23-005428
Filing Date
2023-11-09
Accepted
2023-11-09 16:34:18
Documents
2

Document Format Files

Seq Description Document Type Size
1 AURA BIOSCIENCES, INC. p23-2746sc13da.htm SC 13D/A 49767
2 LOCK-UP AGREEMENT p23-2746exhibit99.htm EX-99 33646
  Complete submission text file 0000902664-23-005428.txt   85058
Mailing Address 1000 WINTER STREET C/O MATRIX CAPITAL MANAGEMENT WALTHAM MA 02451
Business Address 1000 WINTER STREET C/O MATRIX CAPITAL MANAGEMENT WALTHAM MA 02451 781-522-4948
Matrix Capital Management Company, LP (Filed by) CIK: 0001410830 (see all company filings)

IRS No.: 043475951 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 80 GUEST STREET BOSTON MA 01235
Business Address 80 GUEST STREET BOSTON MA 01235 (617)500-8864
Aura Biosciences, Inc. (Subject) CIK: 0001501796 (see all company filings)

IRS No.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92997 | Film No.: 231393174
SIC: 2836 Biological Products, (No Diagnostic Substances)